“The revision of the outlook to stable is due largely to CHS’ recent pattern of weaker earnings,” said S&P analyst Margaret McNamara.
The rating affirmation reflects S&P’s view of CHS’ improving balance sheet and leading market position.
More articles on healthcare finance:
Fitch affirms MultiCare Health System’s ‘AA-‘ rating
Moody’s affirms Summit Health’s ‘A2’ rating
Moody’s revises Mercy Hospital’s outlook to negative
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
